¼¼°èÀÇ ¾Ë·¹¸£±â Áø´Ü ½ÃÀå º¸°í¼­(2025³â)
Allergy Diagnostics Global Market Report 2025
»óǰÄÚµå : 1641490
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,496,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,390,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,284,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾Ë·¹¸£±â Áø´Ü ½ÃÀå ±Ô¸ð´Â ¾ÕÀ¸·Î ¼ö³â°£ ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2029³â¿¡´Â CAGR 13.5%·Î 117¾ï 1,000¸¸ ´Þ·¯·Î ¼ºÀåÇÕ´Ï´Ù. ¿¹Ãø±â°£ÀÇ ¼ºÀåÀº °æÁ¦ ¼ºÀå, ÇコÄɾî ÀÎÇÁ¶óÀÇ È®´ë, °í·ÉÈ­ »çȸÀÇ È®´ë, Á¶±âÁø´Ü°ú ¿¹¹æÀÇ Á߽à µî¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿Çâ¿¡´Â ºÐÀÚ ¾Ë·¹¸£±â Áø´Ü, ¸ÂÃãÇü ¾Ë·¹¸£°Õ ÇÁ·ÎÆÄÀÏ, °¡Á¤¿ë ¾Ë·¹¸£±â °Ë»ç ŰƮ, ÀΰøÁö´É(AI) ÅëÇÕ, ¿ø°Ý ÀÇ·á, ¿ø°Ý ¾Ë·¹¸£±â »ó´ã µîÀÌ Æ÷ÇԵ˴ϴÙ.

¾Ë·¹¸£±â Áúȯ Áõ°¡·Î ¾Ë·¹¸£±â Áø´Ü ½ÃÀåÀÇ È®´ë°¡ ¿¹»óµË´Ï´Ù. ¾Ë·¹¸£±â Áúȯ Áõ°¡´Â ±³Åë Á¤Ã¼ ¹× »ê¾÷ ¹èÃâ¹° µî ´Ù¾çÇÑ ¿øÀÎÀ¸·Î ÀÎÇÑ È¯°æ ¿À¿°ÀÇ ÁõÆø°ú °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ¾Ë·¹¸£±â ¹ÝÀÀÀº ¾Ë·¹¸£°Õ¿¡ ÀÇÇØ À¯¹ßµÇ´Â À¯ÇØÇÑ ¸é¿ª ¹ÝÀÀÀ̸ç, ¾Ë·¹¸£±â¼º ºñ¿°, À½½Ä ¾Ë·¹¸£±â, ÇǺΠ¾Ë·¹¸£±â, õ½Ä µîÀÇ Áõ»óÀ» À¯¹ßÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Áõ»ó¿¡ ´ëÇÑ ÁÖ¿ä Ä¡·á¹ýÀº ¾Ë·¹¸£°Õ¿¡ ´ëÇÑ ³ëÃâÀ» ÇÇÇÏ´Â °ÍÀ̸ç Á¤È®ÇÑ ¾Ë·¹¸£±â Áø´ÜÀº È¿°úÀûÀÎ Ä¡·á¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ¹Ì±¹ ¾Ë·¹¸£±â õ½Ä ¸é¿ªÇÐȸ(American College of Allergy, Asthma, and Immunology: ACAAI)¿¡ µû¸£¸é ¹Ì±¹¿¡¼­ ¾Ë·¹¸£±â ÁúȯÀÇ À¯º´·üÀº ¸ðµç ¿¬·É´ë¿¡¼­ »ó´çÈ÷ ³ôÀ¸¸ç ¼ö¹é¸¸ ¸íÀÌ ¾Î°í ÀÖ½À´Ï´Ù. õ½ÄÀº 600¸¸ ¸í ÀÌ»óÀÇ ¼Ò¾Æ¸¦ Æ÷ÇÔÇÑ ¾à 2,400¸¸ ¸í¿¡, ¾Ë·¹¸£±â´Â ¿¬°£ 5,000¸¸ ¸í ÀÌ»óÀÇ ¹Ì±¹Àο¡°Ô ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¾Ë·¹¸£±â¿¡ ÀÇÇÑ °æÁ¦Àû ºÎ´ãÀº »ó´çÇÑ °ÍÀ¸·Î, ºñ¿ëÀº ¾à 1,800¸¸ ´Þ·¯¿¡ À̸¨´Ï´Ù.

°Ç°­ °ü¸® ÀÎÇÁ¶óÀÇ °­È­´Â ¾Ë·¹¸£±â Áø´Ü ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇコÄɾî ÀÎÇÁ¶ó¿¡´Â ƯÁ¤ Áö¿ª ¹× ±¹°¡¿¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Â ÇコÄÉ¾î ¼­ºñ½º ¹× ¸®¼Ò½ºÀÇ ¿ÏÀüÇÑ ³×Æ®¿öÅ©°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ ÀÇ·á ÀÎÇÁ¶ó´Â ¾Ë·¹¸£±â Àü¹® Ŭ¸®´Ð, Áø´Ü ½Ã¼³, ¾Ë·¹¸£±â Áúȯ Áø´Ü¿¡ ¼÷·ÃµÈ Àü¹® ÀÇ·á Á¾»çÀÚ¿¡°Ô Á¢±ÙÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ¾Ë·¹¸£±â¿Í °ü·ÃµÈ °í¹ÎÀ» °¡Áø »ç¶÷µéÀÌ Àû½Ã¿¡ Á¤È®ÇÑ Æò°¡¸¦ ¹ÞÀ» ¼ö ÀÖ°Ô ÇÕ´Ï´Ù. 2023³â 5¿ù ±âÁØ, Office for National Statistics(±¹°¡ Åë°è±¹)ÀÇ º¸°í¿¡ µû¸£¸é, ¿µ±¹ÀÇ ÇコÄɾî ÁöÃâÀº ´ëÆø Áõ°¡Çϰí ÀÖÀ¸¸ç, 2019³â¿¡ ºñÇØ ½ÇÁúÀûÀ¸·Î ¾à 13.5%(320¾ï ¿µ±¹ ÆÄ¿îµå/387¾ï 8,000¸¸ ´Þ·¯), ¸í¸ñ»ó ¾à 26.8% Áõ°¡Çß½À´Ï´Ù. °Ç°­ °ü¸® ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÀÌ·¯ÇÑ ÁÖ¸ñÇÒ¸¸ÇÑ ÅõÀÚ´Â ¾Ë·¹¸£±â Áø´ÜÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù´Â °ÍÀ» µÞ¹ÞħÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã °æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°è ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ½ÃÀåÀÇ ÃÖ±Ù µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Allergy diagnostics includes tests and procedures to identify specific allergens, such as foods, pollens, or chemicals, that trigger allergic reactions. The primary objective is to accurately detect allergens, enabling healthcare providers to recommend suitable treatments. This enhances the management of allergic conditions.

The main types of allergy diagnostics tests are in-vivo allergy tests, which are performed on the human body to identify the cause of allergic reactions, and in-vitro allergy tests, which are conducted in laboratories using test tubes and Petri dishes to identify allergy-causing substances. Products in the allergy diagnostics market include consumables, instruments, and luminometers. Allergens are categorized into inhaled allergens, food allergens, and drug allergens. Major end-users of allergy diagnostics include diagnostic laboratories, hospital-based laboratories, and academic and research institutes.

The allergy diagnostics market research report is one of a series of new reports from The Business Research Company that provides allergy diagnostics market statistics, including allergy diagnostics industry global market size, regional shares, competitors with an allergy diagnostics market share, detailed allergy diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the allergy diagnostics industry. This allergy diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The allergy diagnostics market size has grown rapidly in recent years. It will grow from $6.32 billion in 2024 to $7.05 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rise in prevalence of allergies, investments in research and development of allergy diagnostics, changing dietary habits and environmental factors, government initiatives, rise in demand for personalized medicine.

The allergy diagnostics market size is expected to see rapid growth in the next few years. It will grow to $11.71 billion in 2029 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to economic growth, expanding healthcare infrastructure, expansion of The aging population, greater emphasis on early diagnosis and prevention,. Major trends in the forecast period include molecular allergy diagnostics, customized allergen profiles, allergy testing kits for home use, integration of artificial intelligence (ai), telemedicine and remote allergy consultations.

The increasing incidence of allergic diseases is set to drive the expansion of the allergy diagnostics market. The uptick in allergic disorders is linked to amplified environmental pollution arising from various sources such as heavy traffic and industrial emissions. Allergic reactions are adverse immune responses triggered by allergens, leading to conditions like allergic rhinitis, food allergies, skin allergies, and asthma. The primary remedy for these conditions involves avoiding exposure to the allergen, making precise allergy diagnostics an integral part of effective treatment. As per the American College of Allergy, Asthma, and Immunology (ACAAI), the prevalence of allergic diseases is considerable in the United States across all age groups, affecting millions. Asthma, affecting about 24 million individuals, including over 6 million children, and allergies impacting more than 50 million Americans annually. The economic burden from allergies is substantial, costing about $18 million in excess.

The enhancement of healthcare infrastructure is anticipated to be a driving force behind the growth of the allergy diagnostics market. Healthcare infrastructure encompasses the complete network of healthcare services and resources available in a specific region or country. This infrastructure enables access to specialized allergy clinics, diagnostics facilities, and expert healthcare practitioners skilled in diagnosing allergic conditions. This system ensures timely and accurate evaluations for individuals dealing with allergy-related concerns. As of May 2023, the Office for National Statistics reports a significant increase in healthcare spending in the UK, which saw a real-term expenditure hike of about 13.5% (£32 billion) ($38.78 billion) and a nominal-term increase of roughly 26.8% (£60 billion) ($72.72 billion) compared to 2019. This notable investment in healthcare infrastructure underlines its vital role in fostering the growth of allergy diagnostics.

A recent trend observed in the allergy diagnostics market is the rise in collaborations and partnerships between companies to develop innovative testing techniques or enhance existing methodologies. An example from August 2022 includes LifeMD, a US-based telehealth company, revealing a strategic partnership between its subsidiary, Cleared, and Allergenis, a US-based predictive data analytics company. This collaboration is designed to leverage Cleared's expertise in allergy telehealth services and Allergenis' peanut allergy diagnostic blood test within the direct-to-customer channel. This trend of strategic partnerships is aimed at mutual innovation and improvement of diagnostic solutions in the allergy diagnostics industry.

Major firms within the allergy diagnostics sector are pioneering cutting-edge technologies like an AI-fueled allergy component testing platform to enhance their market position and drive profitability. An AI-powered allergy component testing platform utilizes advanced artificial intelligence to interpret allergy testing outcomes. For example, in May 2023, Metropolis, an India-based pathology lab and diagnostic center, introduced an AI-driven allergy component testing platform capable of identifying various allergens like respiratory, contact, and food-related. This innovative platform yields detailed insights into individual allergy conditions, facilitating more informed clinical decisions through component-resolved diagnostics (CRD) and AI-enabled analysis.

In July 2024, Roche, a Switzerland-based pharmaceutical company, acquired LumiraDx for an undisclosed amount. This acquisition aims to strengthen Roche's diagnostics portfolio by integrating LumiraDx's technologies, significantly improving patient access to diagnostic testing, particularly in primary care settings. LumiraDx is a US-based healthcare company that provides microfluidic immunofluorescence assays.

Major companies operating in the allergy diagnostics market include BioMerieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC., Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Alcon Laboratories Inc., Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Astra Biotech GmbH, Stallergenes Greer, Diagenics Limited, DST Diagnostische Systeme & Technologien GmbH, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Microtest Laboratories Inc., Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Symbiotix Biotherapies Inc., Eurofins Viracor Inc., VRL Laboratories

North America was the largest region in the allergy diagnostics market in 2024. The regions covered in the allergy diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the allergy diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The allergy diagnostics market includes revenue earned by instruments such as immunoassay analyzers, ELISA analyzers, luminometers, and other instruments that are used to diagnose allergies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Allergy Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on allergy diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for allergy diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The allergy diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Allergy Diagnostics Market Characteristics

3. Allergy Diagnostics Market Trends And Strategies

4. Allergy Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Allergy Diagnostics Growth Analysis And Strategic Analysis Framework

6. Allergy Diagnostics Market Segmentation

7. Allergy Diagnostics Market Regional And Country Analysis

8. Asia-Pacific Allergy Diagnostics Market

9. China Allergy Diagnostics Market

10. India Allergy Diagnostics Market

11. Japan Allergy Diagnostics Market

12. Australia Allergy Diagnostics Market

13. Indonesia Allergy Diagnostics Market

14. South Korea Allergy Diagnostics Market

15. Western Europe Allergy Diagnostics Market

16. UK Allergy Diagnostics Market

17. Germany Allergy Diagnostics Market

18. France Allergy Diagnostics Market

19. Italy Allergy Diagnostics Market

20. Spain Allergy Diagnostics Market

21. Eastern Europe Allergy Diagnostics Market

22. Russia Allergy Diagnostics Market

23. North America Allergy Diagnostics Market

24. USA Allergy Diagnostics Market

25. Canada Allergy Diagnostics Market

26. South America Allergy Diagnostics Market

27. Brazil Allergy Diagnostics Market

28. Middle East Allergy Diagnostics Market

29. Africa Allergy Diagnostics Market

30. Allergy Diagnostics Market Competitive Landscape And Company Profiles

31. Allergy Diagnostics Market Other Major And Innovative Companies

32. Global Allergy Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Allergy Diagnostics Market

34. Recent Developments In The Allergy Diagnostics Market

35. Allergy Diagnostics Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â